Смотреть видео онлайн

Dr. Brose on Vandetanib for Differentiated Thyroid Cancer

   
- HD качество

В базе 36 видео
Dr. Brose on Vandetanib for Differentiated Thyroid Cancer
Загружен 5 февраля 2014
Marcia S. Brose, MD, PhD, assistant professor, Abramson Cancer Center, Department of Otolaryngology, Head & Neck Surgery, Department of Medicine, ...

Dr. Brose Discusses Lenvatinib for the Treatment of Patients With Thyroid Cancer
Загружен 2 сентября 2015
Marcia S. Brose, MD, PhD, associate professor of Otorhinolaryngology, Head and Neck Surgery at the Hospital of the University of Pennsylvania, discusses the ...

Prof. L. Wirth - Advanced differentiated thyroid cancer
Загружен 26 ноября 2015
Listen to the Italian translation here: https://youtu.be/EqxxhfnzwK8 Find out more about ITCO Foundation here:

Dr. Marcia Brose on Sorafenib in Radioactive Iodine-Resistant Thyroid Cancer
Загружен 3 июня 2013
Marcia Brose, MD, PhD, and an assistant professor of otolaryngology and head and neck surgery in the Abramson Cancer Center and the Perelman School of ...

Dr. Marcia Brose Describes Sorafenib in RAI-Resistant Differentiated Thyroid Cancer
Загружен 14 июня 2013
Marcia Brose, MD, PhD, an assistant professor of otolaryngology and head and neck surgery in the Abramson Cancer Center and the Perelman School of ...

Sorafenib Extends Survival in Differentiated Thyroid Cancer
Загружен 3 июня 2013
A new trial has found that sorafenib may help extend the survival of patients with differentiated thyroid cancer. In the phase-III DECISION trial, progression-free ...

Prof. M. Schlumberger - Vandetanib in patients with medullary thyroid cancer
Загружен 18 октября 2016
Listen to the Italian translation here: https://youtu.be/G2BRoVPdMlc Find out more on ITCO Foundation:

Drug combo shows promise in slowing deadly thyroid cancer
Загружен 24 января 2013
Dr. Keith Bible, and oncologist at Mayo Clinic Cancer Center, discusses results of a study on a drug combo that shows promise in slowing a deadly thyroid ...

New Hope for Patients with Thyroid Cancer: Spotlight on Marcia Brose, MD, PhD
Загружен 6 сентября 2013
New Hope for Patients with Thyroid Cancer: Spotlight on Marcia Brose, MD, PhD.

Dr. Langmuir on the Advantages of Vandetanib in Medullary Thyroid Cancer
Загружен 15 марта 2011
Peter Langmuir, M.D. Executive Director, Medical Science AstraZeneca on the Advantages of Vandetanib in Medullary Thyroid Cancer.

News Update: AstraZeneca Plc's Thyroid Drug Yields Positive Phase III Results (AZN)
Загружен 7 июня 2010
06/07/2010 - AstraZeneca Plc (NYSE:AZN) reported a positive result for its thyroid cancer drug, Vandetanib, Monday; the drug yielded the positive results in its ...

Vandetanib Give Medullary Thyroid Cancer Patients A Second Chance
Загружен 24 мая 2011
In April, the U.S. Food and Drug Administration approved the use of vandetanib for the treatment of medullary thyroid carcinoma. MD Anderson's Dr. Robert ...

Dr. Langmuir on Vandetanib in Medullary Thyroid Cancer
Загружен 15 марта 2011
Peter Langmuir, M.D. Executive Director, Medical Science AstraZeneca on Vandetanib in Medullary Thyroid Cancer.

Dr. Sherman Comments on Cabozantinib and Vandetanib in Medullary Thyroid Cancer
Загружен 16 мая 2013
Eric J. Sherman, MD, Head and Neck Oncology Service, Memorial Sloan-Kettering Cancer Center, comments on the use of cabozantinib and vandetinib in ...

Vandetanib improves PFS in thyroid cancer
Загружен 6 ноября 2014
Visit (Hospital Universitario Ramón y Cajal, Madrid, Spain) talks to ecancertv at ESMO 2014 about his work looking ...

 1 2 » 

Мир в онлайне